Answers are grounded in this paper and cite their sources.
Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense against multidrug-resistant Gram-negative organisms. Over the last decade, carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a significant public health threat. This review summarizes the molecular genetics, natural history, and epidemiology of CRE and discusses approaches to prevention and treatment.
No takes yet. Share an insight, caveat, or question.
Temkin et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: